Our understanding and management of atypical hemolytic uremic syndrome (aHUS) have
dramatically improved in the last decade. aHUS has been established as a prototypic …

Atypical hemolytic uremic syndrome (aHUS) is a disease characterized by the triad of
microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury. The …

Atypical hemolytic uremic syndrome (aHUS) is a devastating form of renal thrombotic
microangiopathy. In the last five years, we have finally witnessed a dramatic improvement in …

Tremendous advances have been made in understanding the pathogenesis of atypical
Hemolytic Uremic Syndrome (aHUS), an extremely rare disease. Insights into the molecular …

Atypical hemolytic–uremic syndrome (HUS) is a rare life-threatening disorder characterized
by microangiopathic hemolytic anemia, thrombocytopenia, and ischemic injury to organs …

Atypical hemolytic uremic syndrome (aHUS) is a rare, lifethreatening, chronic, genetic
disease of uncontrolled alternative pathway complement activation. The understanding of …

Atypical hemolytic uremic syndrome (aHUS) is now well recognized to be a disease
characterized by excessive complement activation in the microvasculature. In both the …

Overactivation of the complement alternative pathway drives the pathogenesis of primary
atypical hemolytic uremic syndrome (aHUS). Genetically‐determined or acquired …

Atypical hemolytic uremic syndrome (aHUS) is a rare disease of microangiopathic hemolytic
anemia, thrombocytopenia, and predominant renal impairment. It is characterized by the …

Atypical hemolytic uremic syndrome (aHUS) is a rare renal thrombotic microangiopathy
commonly associated with rare genetic variants in complement system genes, unique to …